Clinical Trials : Adenoid Cystic Carcinoma


Completed	: Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer : Head and Neck Cancer Lung Cancer : 2001-07-11 : Biological: filgrastim Drug: cisplatin
NOT_YET_RECRUITING	: Drug Screening Using Novel IMD in ACC and Salivary Cancers : Adenoid Cystic Carcinoma : 2025-08-06 : Percutaneous CT image-guided placement of the microdevice(s).At least one, and up to 3, devices will be placed in each tumor. Dr
NOT_YET_RECRUITING	: Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma : Adenoid Cystic Carcinoma : 2025-08-06 : REM-422 is a first in class, small molecule mRNA inhibitor that reduces expression of the MYB transcription factor REM-422 will be adm
Completed	: CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC : Adenoid Cystic Carcinoma : 2025-08-06 : First-in-class pan-NOTCH inhibitor, capsule taken orally.
COMPLETED	: Regorafenib in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma : Adenoid Cystic Carcinoma : 2025-08-06 : All eligible patients will receive a starting regorafenib dose of 120 mg daily taken orally for 3 weeks in a 4-week cycle.Patients for whom rego